0001209191-20-007528.txt : 20200207
0001209191-20-007528.hdr.sgml : 20200207
20200207163006
ACCESSION NUMBER: 0001209191-20-007528
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200205
FILED AS OF DATE: 20200207
DATE AS OF CHANGE: 20200207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WAGNER CHARLES F JR
CENTRAL INDEX KEY: 0001223348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20587863
MAIL ADDRESS:
STREET 1: C/O MILLIPORE CORP
CITY: BILLERICA
STATE: MA
ZIP: 01820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-05
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001223348
WAGNER CHARLES F JR
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP and CFO
Common Stock
2020-02-05
4
A
0
3698
0.00
A
7493
D
Common Stock
2020-02-05
4
A
0
10323
0.00
A
17816
D
Represents earned performance shares with respect to a performance stock unit award granted on 04/10/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/05/2020. The earned performance shares will vest in installments beginning on 2/24/2020.
Restricted stock unit award that vests in installments beginning on 02/10/2021.
/s/ Omar White, Attorney-in-Fact
2020-02-07